Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension

Background: Scleroderma-associated pulmonary arterial hypertension (SSc-PAH) is a rare disease characterized by a very dismal response to therapy and poor survival. We assessed the effects of up-front combination PAH therapy in patients with SSc-PAH. Methods: In this prospective, multicenter, open-l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Respir Crit Care Med
Main Authors: Hassoun, Paul M., Zamanian, Roham T., Damico, Rachel, Lechtzin, Noah, Khair, Rubina, Kolb, Todd M., Tedford, Ryan J., Hulme, Olivia L., Housten, Traci, Pisanello, Chiara, Sato, Takahiro, Pullins, Erica H., Corona-Villalobos, Celia P., Zimmerman, Stefan L., Gashouta, Mohamed A., Minai, Omar A., Torres, Fernando, Girgis, Reda E., Chin, Kelly, Mathai, Stephen C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Thoracic Society 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4642204/
https://ncbi.nlm.nih.gov/pubmed/26360334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201507-1398OC
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados